THE

SPARS PANDEMIC

2025 - 2028

By

Søren Nielsen

2021

We all remember "The Event 201 Scenario" who predicted "COVID-19" and financed by Bill Gates, several months before the real pandemic erupted.

"Event 201" held by the Johns Hopkins Center for Health Security on October 18, 2019, which, according to the author, exactly predicted the coronavirus pandemic scenario.

Here is some of what they predicted about "COVID-19."

Event 201 simulates an outbreak of a novel zoonotic coronavirus transmitted from bats to people that eventually becomes efficiently transmissible from person to person, leading to a severe pandemic.

When it starts to spread efficiently from person to person in the low-income, densely packed neighborhoods of some of the megacities in South America, the epidemic explodes.

There is no possibility of a vaccine being available in the first year. There is a fictional antiviral drug that can help the sick but not significantly limit spread of the disease.

The pandemic will continue at some rate until there is an effective vaccine or until 80-90 % of the global population has been exposed.

On February 10, 2021,  published a post, according to which the Johns Hopkins Center for Health Security that is allegedly financed by Bill Gates has developed a new pandemic scenario. (Again, first time was "The Event 201").

According to the post, the Johns Hopkins Center had held training and preparations for the coronavirus pandemic and after several months, the coronavirus pandemic was staged under the same scenario. 

The author adds the links to the official website of the Johns Hopkins Center providing information about Event 201 and SPARS Pandemic.

And now they are here again with a new prediction on a pandemic called "SPARS" which will come in 2025 to 2028.

But this time they will control all the social media, such as the "Internet, Youtube and Facebook", so that only the information they want came out and everyone else will be labeled "Fake News".

The SPARS Scenario.

The setting of SPARS is the world in 2025–2028. 

For this time period, the project team imagined a world that is simultaneously more connected and yet more divided. 

There is nearly universal access to wireless internet for even the poorest persons in the United States. 

Additionally, technological innovations and competition between technology companies have made an even wider range of information technology readily available to all.

In relation to MCM communication more specifically, government agencies like the CDC have increasingly adopted social media technologies, including long-existing platforms such as Facebook, Snapchat, and Twitter, as well as emerging platforms like ZapQ an interface that enables users to aggregate and archive media content from other platforms and communicate with cloud-based social groups based on common interests and current events.

SPARS

The project team named this fictional pathogen the "St. Paul Acute Respiratory Syndrome Coronavirus", or "SPARS" for short, because in the scenario it is first identified in St. Paul, Minnesota.

First, the project team decided to make SPARS have an extended incubation period (7 to 10 days) but a short latent period (4 to 5 days). 

This complicates the scenario because infected persons in the story are capable of spreading the virus for up to 6 days before showing symptoms of the disease themselves.

This feature of SPARS makes isolation procedures in the scenario, like urging people to stay home if they think they might be sick.

Second, the project team decided to make the morbidity and mortality from SPARS both significantly higher in children than adults, and among pregnant women and those with chronic respiratory conditions.

Timeline of Events in the "SPARS Pandemic 2025–2028" Scenario.

2025.

October : The first US deaths occurred due to SPARS. Initially, these deaths were thought to have been caused by influenza.

November : Cases of SPARS were reported across Minnesota and in six other states.

Thanksgiving holiday travel and Black Friday shopping 

facilitated spread of SPARS beyond the Midwest (26 states and multiple other countries by mid-December).

The WHO declared the SPARS pandemic to be a Public Health Emergency of International Concern.

December : No treatment or vaccine for SPARS existed, but there was some evidence that the antiviral Kalocivir could be effective as a therapeutic.

A proprietary vaccine developed and manufactured by a 

multinational livestock conglomerate (GMI) was proposed as a potential foundation for a human vaccine. 

The vaccine was developed to combat an outbreak of a similar respiratory coronavirus in hooved mammal populations in Southeast Asia, but the vaccine had not been licensed by any regulatory authority or tested in humans. 

There were concerns over potential side effects.

2026.

January : The US government contracted CynBio to develop and produce a human SPARS vaccine based on the GMI animal vaccine.

The HHS Secretary invoked the Public Readiness and 

Emergency Preparedness Act (PREP Act) to provide liability protection for the vaccine manufacturer and providers.

 

Congress authorized and appropriated emergency funds under the PREP Act to provide compensation for potential adverse side effects from the vaccine.

Following reports of Kalocivir’s limited success in treating patients with severe SPARS infections, the FDA issued an Emergency Use Authorization (EUA) for the antiviral. 

Kalocivir had been evaluated as a therapeutic for SARS and MERS, and several million doses were maintained in the SNS, which could be deployed as necessary while production capacity was established to meet demand.

The FDA, CDC, and NIH provided seemingly conflicting 

communications regarding the safety and efficacy of 

Kalocivir.

In the United States, public anxiety around SPARS resulted in extensive use of Kalocivir, frequent self-reporting of SPARS symptoms, and a surge in demand for medical care.

By late January SPARS was detected in 42 countries and all US states.

February : A lack of cultural competency in FDA and other governmental communication became apparent among various ethnic groups in the United States.

A video of a 3-year-old vomiting and fainting after taking a dose of Kalocivir was widely and rapidly spread via social media, strengthening opposition to the EUA.

The UK Medicines and Healthcare Products Regulatory 

Agency and the European Medicines Agency jointly 

authorized the emergency use of a new antiviral, VMax, in the United Kingdom and throughout the European Union. 

Some Americans attempted to gain access to VMax online or by traveling to Europe.

April : The CDC publicized an updated (and significantly lower) case fatality rate in the United States; the perception of lesser risk triggered a drop in public interest.

May : Production of Corovax, the SPARS vaccine produced by CynBio, was well underway.

Federal agencies initiated a communications campaign using well-known public figures with mixed results.

Polls indicated a 15–23% increase in SPARS and Kalocivir knowledge nationwide. 

Hip-hop icon BZee had success promoting public health messaging with an online video clip, but he lost credibility when he compared volunteers for Corovax 

trials with "volunteers" from the Tuskegee syphilis study.

 

Similarly, former President Bennett provided a non-committal response when asked if she would want Kalocivir for her new grandson.

Public health agencies discovered that a relatively new social media platform, UNEQL, was being used as a primary means of communication in college-aged populations.

June : Corovax entered the final stage of its expedited review, and production capacity was increased. 

Ten million doses were expected to be available by July with fifty million more in August.

The CDC Advisory Committee on Immunization Practice (ACIP) announced vaccine priority groups.

Healthcare providers were not included as a priority, inciting protests by doctors and nurses across the country.

In order to prioritize distribution of limited Corovax supply, the federal government requested that states report summary information for patient electronic health records (EHRs) to estimate the number of individuals in high-risk populations. 

This effort was met with resistance from the public, who protested the federal government accessing their private medical information.

July :  A week prior to initiating the nationwide vaccination program, damage to a power grid in the Pacific Northwest resulted in a widespread power outage that lasted two weeks. 

State and local public health agencies initiated 

communications programs using posters and flyers to 

promote the vaccination program in the absence of 

electronic media.

Social media efforts across the country promoted the 

vaccination campaign, and crowdsourced data helped to increase efficiency in distributing the vaccine.

August : The Corovax vaccination program met resistance from several groups: alternative medicine proponents, Muslims, African Americans, and anti-vaccination activists. 

Initially operating independently, these groups banded together via social media to increase their influence.

September : Japan announced that it would not approve Corovax for use in Japan in favor of developing and producing its own vaccine.

October : College students predominantly on the East and West coasts staged protests against the unequal global availability of Corovax. 

Vaccination rates among these students were below 

average for college students in other areas of the country.

November : The anti-anti-vaccine movement, formed in the wake of the 2015 measles outbreak in the United States, reignited their efforts to combat the anti-vaccination super-group. 

The FDA, CDC, and other federal agencies also redoubled their communications efforts to promote the Corovax campaign.

An increasing number of post-SPARS pneumonia cases were reported across the country.

December : The nationwide vaccination program was expanded beyond the initial priority populations to include the rest of the country.

Federal agencies initiated a vaccination communication 

program involving targeted online advertisements.

2027.

February : Post-SPARS pneumonia cases stressed inventories of antibiotics across the country. 

The HHS Secretary authorized distribution of the oldest lots of antibiotics from the SNS to supplement the antibiotic supply nationwide.

Tests of antibiotics in the SNS inventory determined that 94% of the remaining antibiotics in the oldest lots maintained sufficient potency. 

Tests conducted in August 2026 provided the basis for extending the expiration of these lots from 2027 

to 2029.

March : Rumors spread via traditional and social media that the government was dispensing expired antibiotics.

Alyssa Karpowitz, a leader in the natural medicine movement, sought medical care at an emergency department after natural remedies failed to resolve her son’s bacterial pneumonia. 

After successful treatment with proper antibiotics from the SNS supply, she touted the benefits of "expired" antibiotics in her social media circles.

April : Crowd-sourced and independent epidemiology analysis of Corovax side effects conflicted with official federal reports.

 

The independent analyses gained popularity in traditional and social media due to visual presentation and interactive content. 

Government attempts to respond with data and 

press releases largely failed.

May : Reports of Corovax side effects began to gain traction. Several parents of children who experienced neurological symptoms after receiving the vaccination sued the federal government and CynBio. 

The lawsuit was dropped when they learned of 

compensation funds available through the PREP Act and the National Vaccine Injury Compensation Trust Fund.

November : Initial reports of long-term side effects of the Corovax vaccine emerged. 

These reports arose primarily from those in the initial priority (high-risk) populations and were few 

in number. 

With little available data and numerous preexisting conditions, initial studies were unable to identify a statistically significant association with any long-term effects.

 

Claims for compensation were placed on indefinite hold until further data could be gathered and analysis completed.

In response to public demand for long-term side effect 

compensation, the HHS Secretary invited Congress to 

conduct an independent investigation of the federal 

compensation process to alleviate concerns of impropriety.

The public and media pressured Congress to increase the funds authorized for compensation under the PREP Act.

2028.

August : The SPARS pandemic was officially declared to be over; however, experts remain concerned about domestic animal reservoirs and the potential for future outbreaks.

SPARS Aftermath : 

The book SPARS Pandemic, a futuristic scenario for public health communicators, was released as part of the Johns Hopkins Center project under co-authorship of seven professors in 2017.

Today, nearly five years since the St. Paul Acute Respiratory Syndrome coronavirus made its global debut, there remain human cases in 14 countries across Europe, Africa, and Asia.

The pandemic officially ended in August 2028, but the virus persists in domesticated animal reservoirs. 

WHO experts hypothesize that small, isolated outbreaks of SPARS were occurring long before the disease emerged

on a global scale in 2025, and they anticipate that future outbreaks will continue to emerge unless countries maintain widespread vaccination coverage.

As the pandemic tapered off, several influential politicians and agency representatives came under fire for sensationalizing the severity of the event for perceived political gain. 

As with many public health interventions, successful efforts to reduce the impact of the pandemic created the illusion that the event was not nearly as serious as experts suggested it would be. 

President Archer’s detractors in the Republican Party seized the opportunity to publicly disparage the President and his administration’s response to the pandemic, urging voters to elect "a strong leader with the best interests of the

American people at heart." 

A widespread social media movement led primarily by outspoken parents of affected children, coupled with widespread distrust of "big pharma," supported the narrative that the development of SPARS MCMs was unnecessary and driven by a few profit-seeking individuals.

Conspiracy theories also proliferated across social media, suggesting that the virus had been purposely created and introduced to the population by drug companies or that it had escaped from a government lab secretly testing bioweapons.

The very real possibility of a future SPARS pandemic necessitates continued commitment to vaccination programs as well as accurate, culturally appropriate, and timely communication from public health agencies across the planet.

While the communication experiences of the SPARS pandemic

of 2025-2028 offer some examples for how this communication can and should occur, they also identify

practices that should be avoided, or at least modified, for responses to future public health emergencies.